Enhancing Therapeutic Outcomes with Novel Drug Delivery Systems: Challenges and the Role of Quality by Design

Novel Drug Delivery Systems (NDDS) have significantly improved pharmaceutical science by addressing the drawbacks of traditional drug delivery methodssuch as low bioavailability, ineffective targeted delivery and rapid degradation. These advanced systems like nanoparticles, liposomes, micelles, and

Authors

J. Ruby (ORCID: https://orcid.org/0000-0003-0584-8150)
K. Selvakumar
Payel Pramanick
D Shanthini

Publication Details

Published: 2025-01-01
DOI: https://doi.org/10.4108/eai.13-11-2024.2355678
Primary Topic: Computational Drug Discovery Methods
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Enhancing Therapeutic Outcomes with Novel Drug Delivery Systems: Challenges and the Role of Quality by Design

J. Ruby, K. Selvakumar, Payel Pramanick, D Shanthini

Jan 1, 2025

Computational Drug Discovery Methods

article

Enhancing Therapeutic Outcomes with Novel Drug Delivery Systems: Challenges and the Role of Quality by Design

J. Ruby, K. Selvakumar, Payel Pramanick, D Shanthini

January 1, 2025article en

Abstract

Openalex Percentile: Top 73%

Computational Drug Discovery Methods

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Enhancing Therapeutic Outcomes with Novel Drug Delivery Systems: Challenges and the Role of Quality by Design — J. Ruby, K. Selvakumar, et al. · (2025) | TGRS Research Map | TGRS